Targeting Microbiota 2020 will be a Virtual and In-Person Congress

We have been closely following updates and evolving guidance from local, national and global agencies for COVID-19. There is still much uncertainty around the coronavirus, and how long our communities may be impacted by the pandemic, but it seems certain that decisions about how we work, travel and gather together will continue to be influenced for weeks and months still to come. Today, we have made the decision to combine In-Person and Virtual conference.

 

If you cannot attend in-person or virtual due to the restriction and time zone difference, you can access on-demand videos to this entire event, including synced audio/video and slides.

All posters will be in PDF format. You can visit them, upload and interact directly with the poster presenter. You can also exchange with speakers via direct or private exchange during the conference.

We will keep you informed of any new decision.

Welcome to Targeting Microbiota 2020

President Targeting Microbiota 2020Dear colleagues,


On behalf of the International Society of Microbiota, we are pleased to inform you that the 8th World Congress on Targeting Microbiota will be organized at UNESCO World Heritage Centre - Paris, France, on
October 21-23, 2020. 

Read More...


Crosstalk between Gut Microbiota, Innate Immune Cells and Endocrine Cells in the Pancreas Regulates Autoimmune Diabetes

Julien Diana Microbiota 2018Dr. Julien Diana from Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France will present his study entitled "Crosstalk between Gut Microbiota, Innate Immune Cells and Endocrine Cells in the Pancreas Regulates Autoimmune Diabetes" during the Targeting Microbiota 2018 Congress, which will be held in Porto, in October 28-30, 2018.

In his presentation, Dr. Diana will highlight: "The gut microbiota is essential for the normal function of the gut immune system. However how the gut microbiota prevents autoimmunity in distant organs remains poorly defined. Our group recently described that the gut microbiota controls the production of antimicrobial peptides (AMPs) by the pancreatic endocrine cells. Importantly, owing to their immunoregulatory properties, AMPs are critical to maintain the immune tolerance in the pancreas. In the NOD mice, a mouse model of autoimmune diabetes, we demonstrated that dysbiosis leads to a defective production of AMPs in the pancreas and to the development of the disease. Our findings reveal a novel interplay between the gut microbiota, the endocrine cells and the immune system that contributes in preventing autoimmune diabetes.”

For more information: www.microbiota-site.com

Microbiota World Congress 2019

bouton more pictures

Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next